About Us

Archives






SEngine Precision Medicine and Gustave Roussy Announce Plan to Launch PARIS® Test in Europe

Posted: October 5, 2021 at 6:08 pm


Prospective joint venture will accelerate precision medicine in Europe by harnessing innovations in high-throughput drug testing, 3D tumor cell culture, and AI analytics established at SEngine Precision Medicine to identify the best personalized therapeutic matches for patients Prospective joint venture will accelerate precision medicine in Europe by harnessing innovations in high-throughput drug testing, 3D tumor cell culture, and AI analytics established at SEngine Precision Medicine to identify the best personalized therapeutic matches for patients

Read the original here:
SEngine Precision Medicine and Gustave Roussy Announce Plan to Launch PARIS® Test in Europe

Related Post

No Comments

No comments yet.

Sorry, the comment form is closed at this time.